
An Asia-based defense-tech supplier explored a strategic acquisition of an Italian manufacturer whose portfolio included dual-use components and military-grade subsystems, with a supply chain touching public tenders and sensitive end-users. Commercially, the logic was clear: secure European production capacity, protect key know-how, and shorten lead times for NATO-adjacent programs. Legally, however, the deal had to be designed from day one around Italy’s Golden Power regime—built on Decree-Law 21/2012—which gives the Italian government special powers to scrutinize transactions involving strategic assets and, where necessary, impose prescriptions or even block operations to protect national security interests.
At the EU level, the file also sat within the wider sensitivity of foreign investment screening: Regulation (EU) 2019/452provides a cooperation framework under which the screening Member State circulates case information and can receive comments from other Member States and a (non-binding) Commission opinion, with the process operating since October 2020. In parallel, the target’s dual-use footprint created an export-control perimeter: Regulation (EU) 2021/821 governs controls not only on exports but also on brokering, technical assistance, transit and technology-related dimensions that can become relevant when know-how, software, documentation, or production capability crosses borders.
The practical challenge was balancing speed and confidentiality with “early mapping” of trigger points: what exactly qualified as strategic activities, which contracts or technologies raised security flags, and how governance and information flows could be structured to remain commercially bankable and regulator-ready—without a late-stage surprise that would force renegotiation or threaten closing.
We ran the transaction as a clearance-driven project rather than a classic M&A process with screening treated as an afterthought. The Golden Power analysis was embedded into the architecture of the deal—transaction perimeter, sequencing, and conditions—so that signing and closing were aligned to a realistic clearance pathway and the parties avoided “standstill” risk (i.e., taking steps that could be seen as implementing sensitive control before authorizations/clearance). This approach reflects the way the Italian regime has evolved in practice, including the government’s ability—where it sees risk—to attach detailed prescriptions that can affect governance, operations, or sensitive lines of business.
On governance, the objective was not to “dodge” scrutiny, but to avoid unintended control implications while remaining fully compliant and transparent. We calibrated reserved matters, board rights, vetoes, information rights and audit mechanisms so the investor obtained genuine protections, while sensitive operational decisions and access to restricted technical information were handled through controlled channels (including clean-team style arrangements where appropriate). In parallel, we coordinated a disclosure strategy that respected confidentiality and business continuity—critical in defense-linked supply chains—while still producing a coherent, readable file for regulators.
Finally, we aligned the FDI/screening workstream with the export-control dimension that often gets missed in deal timetables: ensuring that any transfer of technology, technical documentation, or ongoing technical assistance would be assessed against the dual-use compliance perimeter under the EU framework.
The end result was a transaction structure that stayed commercially workable, protected IP and continuity of supply, and treated the national-security dimension as a managed path to completion rather than a last-minute obstacle—reducing execution risk for the buyer while keeping the target operational and credible with its sensitive counterparties.
Confidentiality note: identifying details have been omitted/modified. Outcomes depend on individual circumstances and authority assessment.